Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

BACKGROUND: The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently characterized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Seeliger, Hendrik, Pozios, Ioannis, Assmann, Gerald, Zhao, Yue, Müller, Mario H., Knösel, Thomas, Kreis, Martin E., Bruns, Christiane J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206939/
https://ncbi.nlm.nih.gov/pubmed/30373552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4973-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados